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Abstract
Background: The validity of the 20-item Center for Epidemiological Studies Depression (CES-D) scale for
depression screening in Hong Kong Chinese patients with type 2 diabetes remains unknown. We aimed to
validate CES-D, compare its psychometric properties with the 9-item Patient Health Questionnaire (PHQ-9),
and explore whether one of the two is more suitable for depression screening in Chinese patients with type 2
diabetes.
Methods: Between June 2010 and July 2011, 545 consecutive Chinese patients with type 2 diabetes who underwent
structured comprehensive assessments completed the CES-D and PHQ-9. Forty patients were retested within 2–4 weeks
by telephone interview and 97 patients were randomly selected to undergo the Mini International Neuropsychiatric
Interview (MINI) by psychiatrists for clinical diagnosis of depression.
Results: The internal consistency (Cronbach’s α) of CES-D was 0.85, with a test-retest correlation coefficient of 0.64. The
area under the curve for CES-D compared to the clinical diagnosis of major depression was 0.85. A cut-off score of ≥21
for CES-D provided the optimal balance between sensitivity (78.3 %) and specificity (74.3 %) and identified
17.8 % (n = 97) of patients with depression. CES-D and PHQ-9 showed moderate agreement in depression
screening (Cohen’s Kappa: 0.45). Compared to non-depressed patients, those who screened positive by PHQ-9 had a
higher HbA1c whereas the glycemic differences were not significant when using CES-D.
Conclusion: The CES-D is a valid screening tool for depression in Chinese type 2 diabetic patients although the PHQ-9
was more discriminative in identifying those with suboptimal glycemic control.
Background
Depression and type 2 diabetes are complex diseases
with rising prevalence [1, 2]. These two chronic condi-
tions frequently coexist resulting in increased risk of
morbidity and mortality with major negative implica-
tions on the individuals, families and society [3, 4]. Inter-
national diabetes guidelines now recommend screening
for psychosocial problems including depression, especially
when self-management is poor [5, 6]. The 20-item Center
for Epidemiological Studies Depression (CES-D) scale and
the 9-item Patient Health Questionnaire (PHQ-9) are two
most widely used self-administered instruments for de-
pression screening [7, 8]. Originally developed for a
general population in a Western setting, both instruments
have been validated in other populations including
American and Hong Kong Chinese community-dwelling
individuals [9–13].
There is emerging evidence suggesting that ethnicity,
culture, and acculturation may lead to response bias
in these instruments [13–15]. We previously reported
the validity of PHQ-9 for depression screening in
Hong Kong Chinese patients with type 2 diabetes
and reported a lower cutoff point (≥7) for significant
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depressive symptoms than the conventional one (≥10)
which was first validated in primary care settings and
obstetrics-gynecology clinics in U.S. [13, 16]. How-
ever, there is a paucity of data on the performance of
CES-D in Chinese patients with type 2 diabetes. In
this study, we aimed to validate CES-D and compare its
psychometric properties with PHQ-9 in community-dwell-




The study design and patient recruitment have been de-
scribed previously [16]. In brief, 601 Chinese outpatients
with type 2 diabetes aged 25–75 years were recruited
consecutively from a hospital-based (Prince of Wales
Hospital) and a community-based (Yao Chung Kit
Diabetes Assessment Centre) diabetes center between
June 2010 and July 2011. All patients underwent a 4-hour
diabetes complication assessment using a structured
protocol provided by the Joint Asia Diabetes Evaluation
Program [17–20]. They were also invited to complete a
set of questionnaires to assess their psychological well-
being. Significant medical and psychiatric history, social
history, family history of diabetes, and medication re-
cords were documented. Urine and blood samples were
collected after overnight fast for plasma glucose, glycated
hemoglobin (HbA1c), total cholesterol, low density-
lipoprotein cholesterol (LDL-C), high density-lipoprotein
cholesterol (HDL-C), triglycerides, renal function, and
urinary albumin-to-creatinine ratio (ACR). This study
was approved by the ethics committee of The Chinese
University of Hong Kong, and all patients gave informed
consent.
Psychological assessment
Symptoms of depression were assessed by the CES-D
and PHQ-9 questionnaires. The CES-D scale is a 20-
item self-reported instrument developed by Radloff in
1977 [7]. It measures the frequency of common depres-
sive symptoms over the past week. Each item is scored
from 0 (rarely or none of the time, less than one day) to
3 (all of the time, 5–7 days). The four positively stated
items (item 4, I felt that I was just as good as other
people; item 8, I felt hopeful about the future; item 12, I
was happy; item 16, I enjoyed life) are reverse-coded for
calculating the total score which ranges from 0 to 60.
The cut-off value of ≥16 has been widely used to define
clinically meaningful depressive symptoms [7, 21]. It was
reported to have 96.8 % sensitivity and 67.6 % specificity
for clinical depression in Chinese type 2 diabetic patients
attending a diabetes centre in Singapore [22]. The
PHQ-9 focuses on the frequency of occurrence of 9
depressive symptoms derived from DSM-IV diagnostic
criteria over the past two weeks [8]. Each item is
scored from 0 (not at all) to 3 (nearly every day),
with a total score ranging from 0 to 27. A cutoff value of
10 has been widely used to define probable depression,
with 88 % sensitivity and 88 % specificity in the original
validation study with majority of participants being
Caucasians [8]. In our previous criterion validation in
the same group of 99 patients, we identified the opti-
mal value of 7 with 82.6 % sensitivity and 73.7 %
specificity [16].
The process of this study has been described previ-
ously [16]. Briefly, 40 patients were randomly selected
for CES-D and PHQ-9 retest within 2–4 weeks by tele-
phone survey. Another randomly selected subset of
patients was referred for assessment by psychiatrists
(Dr Marco Lam and Dr Siu-ping Lam) using the
Chinese version of Mini International Neuropsychiatric
Interview (MINI version 6.0), a short structured diagnos-
tic interview that has been validated and is widely ac-
cepted for diagnosing major depression in a research
setting [23, 24]. Due to manpower issue, patient was
assessed by one psychiatrist only and we were not able to
calculate the inter-rater reliability. However the two
psychiatrists received training for MINI together.
Pilot interview was conducted in three patients and
it showed 100 % agreement in the MINI diagnosis
for depression.
Statistical analyses
All analysis was performed using the Statistical Package
for Social Sciences (SPSS version 20.0, IBM). Data were
expressed as mean ± SD, median (interquartile range)
or number (%), as appropriate. The Student’s t-test,
Mann–Whitney U test and Chi-square tests were used
for group comparisons. Cronbach’s α was calculated to
evaluate the internal consistency. Pearson correlation
coefficients were used to measure test-retest correl-
ation and concurrent validity of the PHQ-9 and CES-D
as appropriate. Item discrimination was tested by
corrected item-total correlation using the Pearson
product–moment correlation formula, which has been
incorporated into SPSS Reliability analysis. Exploratory
factor analysis (EFA) with eigenvalue >1 criteria was per-
formed to establish the construct validity. An oblique
(Promax) rotation was used in the EFA based on the as-
sumption that the CES-D would have correlated factors.
The response agreement between PHQ-9 and CES-D
was evaluated with Cohen’s kappa. Receiver Operator
Characteristic (ROC) analysis was used to determine the
diagnostic performance and optimal cutoff score for
screening major depression against MINI-based clinical
diagnosis. AP value < 0.05 (2-tailed) was considered
significant.
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Results
Characteristics of study participants
A total of 545 participants (mean age 54.6 ± 9.5 years,
median[IQR] disease duration 6 [3–11] years, 41.3 %
were female) fulfilled the inclusion criteria and had
complete CES-D and PHQ-9 data for analysis, among
them 97 underwent clinical interview by psychiatrists.
Their characteristics were presented in Table 1. Overall,
4.8 % (n = 26) of patients had a history of clinical diag-
nosed psychiatric disorder, mostly consisting of depres-
sion (n = 18), and 8.2 % (n = 44) of patients were
concurrently treated with psychotropic medications. 28
(5.1 %) had suicide ideation in the past 2 weeks based
on the 9th item of PHQ-9. Of them, 22 (4.0 %), 5 (0.9 %)
and 1 (0.2 %) reported suicide ideation for a few days, more
than half the days and nearly every day, respectively.
Psychometric properties of the CES-D
Internal reliability and item discrimination
The internal consistency (Cronbach’s α) of CES-D was
0.85, with test-retest correlation coefficient (r) of 0.64
(P < 0.001), similar to PHQ-9 (α = 0.87, r = 0.70, P < 0.001)
as shown in our previous study [16]. After removal of the
four positive affective items in the CES-D the internal
consistency of CES-D questionnaire increased to 0.91. The
corrected item-total correlations for individual CES-D
items ranged from 0.17 (item 4: feeling good) to 0.66
(item 6: depressed) (Table 2), lower for the four posi-
tive items than other items. The corrected item-total
correlations for individual PHQ-9 items ranged from
0.48 to 0.68 [16].
Construct validity and item scores of CES-D
The Kaiser-Meyer-Olkin test of sampling adequacy
was 0.91 and Bartlett’s test of sphericity was significant
(X2 = 5042.6, P < 0.001). EFA using Promax rotation
procedure yielded a four-factor structure for the CES-D
according to the “eigenvalue >1” rule: 1) depressed affect,
2) somatic symptoms, 3) positive affect, and 4) interper-
sonal problems. The scree plot was shown as Fig. 1. This
four-factor model accounted for 61.1 % of the scale vari-
ance, with factor loadings ranging from 0.62 to 0.88
(Table 2).
The mean CES-D total score was 13.0 ± 8.6 (median12.0,
IQR 7.0-17.0), with individual item scores ranging from
0.14 to 1.65. The four positive affect items scored much
higher than the other items, with a mean factor score of
5.9 ± 3.9, accounting for 50 % of the total CES-D score.
The positive affect factor did not correlate with the somatic
symptoms (r = −0.05,P = 0.275), depressed affect (r = 0.04,
P = 0.414), or interpersonal problems (r = −0.02, P = 0.703);
the latter three factors were significantly inter-correlated,
with correlation coefficients ranging from 0.49 to 0.75
(all P < 0.001) (Table 2)
Diagnostic validity
Among the 97 patients who were interviewed by two
psychiatrists, 23 patients had a clinical diagnosis of
current major depressive episode as measured by the
MINI. The area under the curve (AUC) upon ROC ana-
lysis was 0.85(95%CI: 0.77-0.92) (Fig. 2). The standard
cut-off score of ≥16 for CES-D had an excellent sensitiv-
ity (91.3 %) but low specificity (60.8 %) compared to the
MINI diagnosis of major depressive episode. As shown
in Table 3, a cut-off score of ≥21 on CES-D yielded an
optimal balance between sensitivity (78.3 %) and specifi-
city (74.3 %), with positive predictive value (PPV) of
48.6 %, and negative predictive value (NPV) of 91.7 %,
similar to the PHQ-9 score ≥ 7. Furthermore, the re-
moval of the four positive items slightly improved the
diagnostic performance (Cronbach’s α 0.91, AUC 0.85
[0.77-0.94]), where the optimal cutoff value of 14 yielded
a sensitivity of 82.6 % and specificity of 74.3 % (PPV
50.0 %, NPV 93.2 %).
Comparison of CES-D and PHQ-9
If the conventional cut-off points (score of ≥16 for
CES-D and ≥10 for PHQ-9) were adopted, 31.0 %
and 9.0 % of patients were respectively identified to
have depression by CES-D and PHQ-9, with fair
chance-corrected agreement between the two instru-
ments (Cohen’s kappa: 0.32). However if we used a
score of 21 as the cut-off for CES-D, 17.8 % of pa-
tients were identified to have possible depression,
similar to the depression prevalence reported in the
same group of patients using the PHQ-9 ≥ 7 [16],
with moderate chance-corrected agreement between
the two instruments (Cohen’s kappa: 0.45). The over-
lap of depressive symptom screen positivity is illus-
trated in a Venn diagram (Fig. 3), where just over a
third of the 545 patients were captured by both
PHQ-9 ≥ 7 and CES-D ≥21.
Overall, the demographic and clinical patterns of de-
pression versus non-depression were similar using either
PHQ-9 or CES-D as the screening instrument. However,
patients with depression by PHQ-9 had significantly
higher HbA1c level while there was no such difference
between the depressed and non-depressed groups
defined by the 20-item CES-D (Table 1), nor did by the
16-item CES-D (7.6 ± 1.7 vs. 7.5 ± 1.4 % [59.2 ± 18.4 vs.
58.6 ± 15.2 mmol/l], P = 0.734). Similarly, PHQ-9 score
as a continuous value was positively associated with high
HbA1c level (r = 0.12, P = 0.004) but not for CES-D score
(r = 0.03, P = 0.423). Patients positive for both CES-D
(≥21) and PHQ-9 (≥7) had similar HbA1c to those posi-
tive only for PHQ-9 (7.9 ± 1.9 vs. 7.9 ± 2.1 % [62.5 ± 20.6 vs.
62.4 ± 22.5 mmol/l], P = 1.000) but higher HbA1c than
those positive only for CES-D although it did not
reach statistical significance (7.9 ± 1.9 vs. 7.4 ± 1.3 %
Zhang et al. BMC Psychiatry  (2015) 15:198 Page 3 of 10
Table 1 Demographic and clinical characteristics of Chinese type 2 diabetic patients categorised by validated cutoff values of PHQ-9
and CES-D
Total CES-D <21 CES-D ≥21 p value PHQ-9 < 7 PHQ-9≥ 7 P value
Number 545 448 97 (17.8) 449 96 (17.6)
CES-D score 13.0 ± 8.6 9.9 ± 5.3 27.4 ± 5.6 <0.001 11.0 ± 6.9 22.3 ± 9.5 <0.001
PHQ-9 score 3.5 ± 4.4 2.3 ± 2.7 8.8 ± 6.2 <0.001 1.8± 1.8 11.2± 4.6 <0.001
Age (years) 54.6 ± 9.5 54.7 ± 9.7 54.4 ± 8.6 0.807 54.4 ± 9.4 55.4 ± 9.9 0.339
Women 225 (41.3) 173 (38.6) 52 (53.6) 0.007 170 (37.9) 55 (57.3) <0.001
Disease duration (years) 6.0 (3.0,11.0) 7.0 (3.0,10.3) 6.0 (3.0,13.0) 0.867 7.0 (4.0,10.8) 6.0 (2.0-13.0) 0.568
Education 0.555 0.073
Illiterate/primary school 142 (26.1) 117 (26.1) 25 (25.8) 113 (25.2) 29 (30.2)
Middle school 275 (50.5) 222 (49.6) 53 (54.6) 222 (49.4) 53 (55.2)
High school and above 128 (23.5) 109 (24.3) 19 (19.6) 114 (25.4) 14 (14.6)
In employment 307 (56.3) 259 (57.8) 48 (19.5) 0.134 266 (59.2) 41 (42.7) 0.003
Current smoker 56 (10.3) 49 (11.0) 7 (7.2) 0.271 43 (9.6) 13 (13.5) 0.249
Exercise ≥3 times/week 262 (48.1) 216 (48.2) 46 (47.4) 0.887 217 (48.3) 45 (46.9) 0.796
SMBG≥weekly 278 (51.0) 234 (52.2) 44 (45.4) 0.22 232 (51.7) 46 (47.9) 0.504
Cardio-metabolic risk factors
Body mass index (kg/m2) 26.1 ± 4.4 26.1 ± 4.3 26.0 ± 4.9 0.802 26.1 ± 4.4 26.0 ± 4.6 0.902
Systolic BP (mmHg) 130.6 ± 15.7 130.3 ± 15.5 132.3 ± 16.7 0.255 130.4 ± 15.6 131.7 ± 16.2 0.464
Diastolic BP (mmHg) 79.6 ± 10.0 79.3 ± 9.9 80.9 ± 10.5 0.158 79.5 ± 10.0 80.2 ± 10.2 0.510
Waist circumference, men (cm) 91.2 ± 10.5 91.1 ± 10.2 91.8 ± 12.1 0.713 91.3 ± 10.4 90.7 ± 11.3 0.742
Waist circumference, women (cm) 86.1 ± 11.1 85.8 ± 10.9 87.2 ± 11.7 0.421 85.8 ± 11.5 87.0 ± 10.0 0.475
HbA1c (%) 7.5 ± 1.4 7.5 ± 1.4 7.7 ± 1.6 0.238 7.4 ± 1.3 7.9 ± 1.9 0.045
HbA1c (mmol/L) 58.6 ± 15.7 58.3 ± 15.2 60.4 ± 18.0 0.238 57.8 ± 14.2 62.4 ± 21.2 0.045
Total cholesterol (mmol/L) 4.50 ± 0.88 4.48 ± 0.87 4.60 ± 0.91 0.247 4.52 ± 0.89 4.40 ± 0.84 0.200
HDL-C (mmol/L) 1.34 ± 0.37 1.33 ± 0.37 1.35 ± 0.36 0.632 1.35 ± 0.37 1.30 ± 0.37 0.223
LDL-C (mmol/L) 2.49 ± 0.71 2.48 ± 0.70 2.56 ± 0.75 0.284 2.51 ± 0.71 2.42 ± 0.72 0.324
eGFR (ml/min/1.73 m2) 109.0 ± 23.7 109.3 ± 23.4 108.1 ± 24.9 0.654 109.3 ± 23.8 108.0 ± 23.2 0.653
Spot urinary ACR 1.10 (0.48,4.02) 1.09 (0.48,3.90) 1.11 (0.51,4.56) 0.442 1.05 (0.44,3.90) 1.25 (0.62,5.03) 0.096
Hypertension 430 (78.9) 356 (79.5) 74 (76.3) 0.487 349 (77.7) 81 (84.4) 0.147
Dyslipidaemia 463 (85.3) 383 (85.9) 80 (82.5) 0.345 380 (85.0) 83 (86.5) 0.717
Albuminuria 166 (30.5) 136 (30.4) 30 (30.9) 0.912 135 (30.1) 31 (32.3) 0.667
Diabetes-related complications
Cardiovascular disease 53 (9.7) 42 (9.4) 11 (11.3) 0.554 40 (8.9) 13 (13.5) 0.164
Retinopathy 112 (20.6) 91 (20.3) 21 (21.6) 0.786 95 (21.2) 17 (17.7) 0.448
Chronic kidney disease 10 (1.8) 8 (1.8) 2 (2.1) 0.695 8 (1.8) 2 (2.1) 0.689
Sensory neuropathy 13 (2.4) 7 (1.6) 6 (6.2) 0.016 7 (1.6) 6 (6.2) 0.015
Medication, target achievement
Use of insulin 87 (16.0) 73 (16.3) 14 (14.4) 0.65 73 (16.3) 14 (14.6) 0.684
On OAD 492 (90.3) 402 (89.7) 90 (92.8) 0.358 402 (89.5) 90 (93.8) 0.206
Use of antihypertensive drugs 324 (59.4) 269 (60.0) 55 (56.7) 0.543 261 (58.1) 63 (65.6) 0.704
Use of lipid lowering drugs 265 (48.6) 223 (49.8) 42 (43.3) 0.247 208 (46.3) 57 (59.4) 0.02
Concurrent use of psychotropic drugs 44 (8.2) 16 (4.3) 28 (16.7) <0.001 27 (6.1) 17 (17.7) <0.001
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[62.5 ± 20.6 vs. 57.8 ± 14.5 mmol/l], P = 0.206). Moreover,
using PHQ-9 ≥ 7 as the cutoff value, patients with depres-
sion were more likely to use lipid lowering drugs. Such dif-
ference was not detected if we used CES-D ≥21 to define
depression.
Discussion
To our best knowledge, this is the first study to validate
CES-D and systematically compare it with the PHQ-9
for depression screening in Chinese patients with type 2
diabetes. The internal consistency, test-retest reliability,
Table 1 Demographic and clinical characteristics of Chinese type 2 diabetic patients categorised by validated cutoff values of PHQ-9
and CES-D (Continued)
HBA1C < 7.0 % (53 mmol/L) 218 (40.0) 181 (40.4) 37 (38.1) 0.681 187 (41.6) 31 (32.3) 0.089
LDL-C < 2.6 mmol/L 312 (57.2) 255 (56.9) 57 (58.8) 0.739 252 (56.1) 60 (62.5) 0.252
BP < 130/80 mmHg 206 (37.8) 173 (38.6) 33 (34.0) 0.397 175 (39.0) 31 (32.3) 0.22
PHQ-9 Patients Health Questionnaire-9, CES-D 20-item Center for Epidemiological Studies Depression, SMBG Self-monitoring of blood glucose, BP Blood pressure,
eGFR estimated glomerular filtration rate, ACR albumin-to-creatinine ratio, OAD Oral antidiabetic drugs
Data are shown as mean ± SD, number (%) or median (interquartile range)
The definitions of risk factors and complications were as follows: hypertension = known high blood pressure with or without treatment and/or blood
pressure ≥ 130/80 mmHg; dyslipidaemia = LDL-C ≥ 2.6mmol/L, HDL-C < 1.0 mmol/L, triglycerides ≥ 2.3 mmol/L, or on any lipid-lowering agents; albuminuria =
sport urine albumin/creatinine ratio ≥ 2.5 mg/mmol in men or ≥ 3.5 mg/mmol in women; chronic kidney disease = eGFR <60 ml/min/1.73 m2, cardiovascular disease = cor-
onary heart disease, stroke, and/or peripheral vascular disease
Table 2 Item scores, internal reliability, factor loadings and inter-factor correlations of CES-D
Score Internal reliability (α = 0.852) Factor loadingsb




Factor 1 Factor 2 Factor 3 Factor 4
1. I was bothered by things that usually don’t bother me. 0.72 0.84 0.56 0.73
2. I did not feel like eating; my appetite was poor. 0.36 0.68 0.31 0.65
3. I felt that I could not shake off the blues even with help
from my family or friends.
0.40 0.71 0.62 0.69
4. I felt I was just as good as other people. 1.65 1.19 0.17 0.86 0.77
5. I had trouble keeping my mind on what I was doing 0.49 0.70 0.50 0.69
6. I felt depressed. 0.47 0.72 0.66 0.77
7. I felt that everything I did was an effort. 0.48 0.72 0.48 0.65
8. I felt hopeful about the future 1.50 1.20 0.21 0.86 0.80
9. I thought my life had been a failure. 0.44 0.77 0.56 0.67
10. I felt fearful 0.44 0.74 0.62 0.76
11. My sleep was restless. 0.66 0.85 0.46 0.64
12. I was happy. 1.39 1.16 0.33 0.85 0.87
13. I talked less than usual. 0.61 0.84 0.51 0.62
14. I felt lonely. 0.45 0.76 0.63 0.73
15. People were unfriendly 0.39 0.66 0.51 0.88
16. I enjoyed life. 1.36 1.19 0.30 0.86 0.88
17. I had crying spells. 0.35 0.68 0.46 0.74
18. I felt sad 0.39 0.70 0.64 0.87
19. I felt that people dislike me 0.33 0.62 0.43 0.88
20. I could not get “going.” 0.14 0.48 0.51 0.65
Factor score 3.1 ± 4.2 3.3 ± 3.2 5.9 ± 3.9 0.7 ± 1.2
Inter-factor correlation
Factor 1 1.00 0.75* 0.04 0.53*
Factor 2 1.00 −0.05 0.49*
Factor 3 1.00 −0.02
aOnly those with increased Cronbach’s α if item deleted were shown in the table
bFactor 1: Depressed affect; factor 2: somatic symptoms; factor 3: positive affect; factor 4: Interpersonal problems
*P for Pearson correlation (r) <0.0001. The correlations between positive affect and other subscales were not significant
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and diagnostic performance of CES-D was comparable
with that of the PHQ-9, which had been validated in the
same population [16].
Factor structure of CES-D
The four-factor structure of CES-D was similar to the
original one proposed by Radloff [7], except that item 20
(“get going”) loaded in the depressed affect factor but
not the somatic symptom factor in our Chinese patients
with type 2 diabetes. These subtle variations in factor
structure might be due to racial/ethnic or culture differ-
ences [25, 26]. In a meta-analysis on CES-D factor struc-
ture, people from different cultures might conceptualize
depressive symptoms in different ways. Besides, the
Fig. 1 The scree plot for CES-D exploratory factor analysis
Fig. 2 Receiver operating characteristic (ROC) curve analysis of CES-D and PHQ-9 versus clinical interview by MINI in 97 Chinese patients with
type 2 diabetes
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analytic methods used to load various factors, e.g. con-
firmatory factor analysis (CFA) versus EFA, could also
influence the results of CES-D factor structure [25]. In
another study involving 138 Hong Kong Chinese mar-
ried couples (aged 22–70 years) which used CFA to val-
idate the CES-D, the authors reported a 2-factor model
(depression and interpersonal problems) [11] compared
to the 4-factor model in our study.
In this study, the positive affect factor did not correlate
with the other three factors (inter-factor correlation
ranged from −0.05 to 0.04), contrary to many other
studies in United States (ranged from 0.31 to 0.85)
[27–29]. Traditional Chinese and Oriental culture
emphasizes modesty, silence, stoicism, and emotional
restraint. These beliefs might influence our patients
not to endorse positively-stated items in the CES-D
(e.g. “I was happy”, the score was reversed during calcula-
tion) despite having other negative symptoms, leading to
an elevated score on positive affect problems. Our results
are consistent with other studies in Chinese subjects [14,
30]. In a study of 168 community-dwelling American
Chinese women, native Chinese speakers or Chinese im-
migrants were 50 % less likely to endorse the four positive
items than English speakers or subjects born in United
States, albeit having similar mean scores for the other 16
items [14]. This discrepancy has also been reported in
other studies probably due to culture influences [30, 31].
American Koreans who were less acculturated to Ameri-
can views were less likely to endorse positive CES-D items
than the more acculturated ones [32]. Compared to Amer-
icans, Japanese had spuriously lower ratings of positive
items whereas the scores for the negative items were com-
parable between the two groups [30]. Taken together,
these cultural or ethnic factors seemed to affect responses
to the four positive affect items which might compromise
the validity of CES-D. In support of this, the performance
of CES-D improved upon exclusion of these 4 positive
affect items suggesting that the 16 item CES-D is a better
screening tool for depression than the 20 item CES-D, at
least in Chinese subjects.
Higher cut-off point of CES-D in Chinese
Our results suggested an optimal cutoff value of 21,
which is higher than the widely used cutoff value of 16
(sensitivity 91.3 %, specificity 60.8 %). Different study de-
signs, settings and populations may contribute to differ-
ences in the performance of different cutoff values [33].
Table 3 Diagnostic performance for detection of major depressive
disorder using MINI clinical interview as reference (n = 97)
Cutoff
value
Sensitivity Specificity LR+ LR- PPV NPV
20-item CES-D
≥16 91.3 % 60.8 % 2.33 6.99 42.0 % 95.7 %
≥17 87.0 % 64.9 % 2.47 4.97 43.5 % 94.1 %
≥18 78.3 % 67.6 % 2.41 3.11 42.9 % 90.9 %
≥19 78.3 % 71.6 % 2.76 3.29 46.2 % 91.4 %
≥20 78.3 % 71.6 % 2.76 3.29 46.2 % 91.4 %
≥21 78.3 % 74.3 % 3.05 3.42 48.6 % 91.7 %
≥22 73.9 % 77.0 % 3.22 2.95 50.0 % 90.5 %
16-item CES-D
≥13 82.6 % 73.0 % 3.06 4.20 48.7 % 93.1 %
≥14 82.6 % 74.3 % 3.22 4.27 50.0 % 93.2 %
≥15 73.9 % 78.4 % 3.42 3.01 51.5 % 90.6 %
PHQ-9
≥6 87.0 % 68.9 % 2.80 5.28 46.5 % 94.4 %
≥7 82.6 % 73.0 % 3.06 4.20 48.7 % 93.1 %
≥8 73.9 % 77.0 % 3.22 2.95 50.0 % 90.5 %
≥9 60.9 % 83.8 % 3.75 2.14 53.8 % 87.3 %
≥10 56.5 % 83.8 % 3.49 1.93 52.0 % 86.1 %
LR+ Positive likelihood ratio, LR- Negative likelihood ratio, PPV Positive
predictive ratio, NPV Negative predictive ratio
Fig. 3 Venn diagram. a for those with MINI interview; b among all
the patients
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Consistently, in studies involving Chinese subjects,
the latter tended to have higher CES-D cut-off points
in depression screening than Caucasian populations
[12, 22, 34]. For example, a CES-D validation study
in Hong Kong involving 398 elderly individuals re-
ported an optimal cutoff value of 22 (75 % sensitivity
and 51 % specificity), while the conventional cutoff value
of 16 had high sensitivity (92 %) but poor specificity (30 %)
in detecting depression [12]. In another CES-D validation
study in Singaporean Chinese adults using the Schedule
for Clinical Assessment in Neuropsychiatry (SCAN) as cri-
terion, the cutoff value of 16 had specificity of 67.6 % only,
although the sensitivity was high (96.8 %) [22].
Comparison of CES-D to PHQ-9
In line with other studies [35, 36], our findings showed
that both PHQ-9 and CES-D showed similar psycho-
metric performances with respect to the internal
consistency, test-retest reliability, and diagnostic validity
against MINI-based diagnostic interview. Using the
standard cutoff point (≥16), CES-D identified more than
30 % of patients with possible depression, much higher
than using the standard cutoff point ≥10 of PHQ-9
(9.0 %, Cohen’s Kappa = 0.32). This finding is consistent
with a recent study in systemic sclerosis where Milette
and colleagues compared the PHQ-9 to CES-D in 566
patients with systemic sclerosis and found CES-D ≥ 16
identified 34.3 % patients with possible depression, while
PHQ-9 ≥ 10 identified 20.7 % (Cohen’s Kappa = 0.49),
suggesting that PHQ 9 is more specifically indicative of
depression while the CES-D is capturing some of the
depression and some of the other emotions present in
serious illness.
Compared to conventional cutoff, the CES-D had a
higher cutoff value while PHQ-9 had a lower cutoff
value. This disparity might be partly explained by the
content differences of the two tools. The PHQ-9 is con-
structed on the basis of the DSM-IV diagnostic criteria
for clinical depression; while the CES-D measures de-
pressive symptomatology with emphasis on the affective
component and depressed mood [7]. Besides, the PHQ-9
asks about the frequency of depressive symptom in the
past two weeks, while the CES-D asks about the fre-
quency of symptoms in the past one week. The shorter
duration covered by the CES-D may have captured
short-term symptoms including acute hassles and
stressors which might not reflect true depression. Be-
sides, since Chinese people tend to give negative re-
sponse to positive affect items, this may also lead to a
higher score of CES-D in our study population.
While the use of PHQ-9 (≥7 or ≥ 10) identified pa-
tients with significant depressive symptoms which were
associated with poor glycemic control and increased use
of lipid-lowering drugs, such association was not found
in patients with depressive symptoms detected by
CES-D, suggesting that CES-D might identify patients
with slightly different profile than those identified by
PHQ-9. When evaluating other studies that have examined
the association between depression and glycemic control,
findings have been mixed where some studies have found
an association between depressive symptoms and poor gly-
cemic control whereas others have not [37, 38]. Our results
raise the possibility that this inconsistency might be in part
due to the different tools used in capturing depressive
symptoms. Here, negative emotions can be heterogeneous
and complex with different combinations of symptoms
which may have common but also distinct biological path-
ways. This complexity may also explain the inconsistency
regarding the associations between depression and gly-
cemic control.
Although theoretically, the CES-D and the PHQ-9
may complement one another to detect depression and
negative emotions, this may be not feasible in real-world
practice given increased time of testing and redundancy
of the items. However, since the two tools cover different
time frame (1 week versus 2 weeks) with slightly differ-
ent attributes (eg. interpersonal problems in CES-D and
suicidal tendency in PHQ-9) and complementary aspects
as revealed by the Venn diagram, it might be useful to
explore the possibility of selecting items from both tools
to generate a better depression screening algorithm in
future studies.
Both PHQ-9 and CES-D had different cutoff values
with PHQ-9 being a better tool than the CES-D in iden-
tifying Chinese type 2 diabetic patients with both de-
pression and poor glycemic control. These results
highlighted the importance of validating screening tools
in local settings. The differences in associations of de-
pression with glycemic control between the two instru-
ments also support the syndromic nature of depression
due to possible subphenotypes and aetiologies with vari-
able responses to different screening tools. In this study,
we also observed a high suicide risk in these patients
that 5 % had suicide ideation using the PHQ-9. Consist-
ently, a study in Italy found more severe suicide ideation
in patients with diabetes and its severity was closely
associated with older age, polytherapy and lower self-
efficacy [39]. Therefore, these results warrant depression
screening and subsequent emotional support for patients
with diabetes.
Limitations
Although the study population comprised of self-
referred patients and those referred by family clinics, the
majority of them were attending hospital-based specialist
out-patient clinics, who might have more severe disease,
longer disease duration, multiple co-morbidities, and
more complicated drug regimens than the typical
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outpatient community-based patients. Thus, our cohort
might not fairly represent the general Hong Kong Chinese
population with type 2 diabetes. Furthermore, this study
was performed in Hong Kong, which has a different health
care system and different cultural nuances than that of
Mainland China, so caution must be taken when making
generalizations to the wider Chinese population. Finally,
only a subset of our cohort had a diagnostic interview as
the criteria validation measure, so further studies with lar-
ger sample sizes are required to confirm these findings.
Conclusions
In summary, the CES-D is a validated tool for detecting
major depression in Chinese patients with type 2 dia-
betes. The improvement in performance after excluding
items on positive affect might reflect cultural differences.
Between CES-D and PHQ-9, the latter is a preferred
screening tool due to its longer coverage period, fewer
items associated less administering time, and ability to
identify depressed patients with poor metabolic control.
The different cutoff values in our population also
emphasize the importance of calibrating these tools in
different patient groups and settings.
Competing interests
J.C. is the Chief Executive Officer of the Asia Diabetes Foundation on a probono
basis. She has received honorarium for consultancy or giving lectures from Bayer,
Boehringer Ingelheim, Daiichi-Sankyo, Eli-Lilly, GlaxoSmithKline, Merck Sharp &
Dohme, Merck Serono, Pfizer, Astra Zeneca, Sanofi, Novo-nordisk and/or
Bristol-Myers Squibb. YKW has received sponsorship from Lundbeck Export
A/S, Servier Hong Kong Ltd and Celki Medical Company and was a part-time
paid consultant for Renascence Therapeutics Limited. A.K. has received
honorarium for consultancy or giving lectures from Nestle Nutrition Institute,
Merck Serono, Pfizer, Eli Lilly, Roche, Sanofi, Jassen and Astra Zeneca. N.S. has
been given honoraria for participating in scientific meetings organized by
Lilly, Servier, and Takeda, and his association has received unrestricted grants
from Lilly, Lundbeck and Pfizer. No other potential conflicts of interest relevant
to this article were reported.
Authors’ contribution
YZ researched data, contributed to the discussion, and wrote, reviewed,
and edited the manuscript. RT contributed to the discussion, and wrote,
reviewed, and edited the manuscript. ML, SL and HN researched data,
contributed to the discussion and reviewed the manuscript. RY, AK, AL, and
RO contributed to the discussion, reviewed, and edited the manuscript.
YKW, NS and JC conceptualized the study, contributed to the discussion,
and reviewed and edited the manuscript. JC finalized the manuscript. All
authors read and approved the final manuscript.
Acknowledgement
We gratefully acknowledge Dr. Larry Cimino of the Dialogue for Diabetes
and Depression, Ms. Rebecca Wong, nurse consultant, Ms. Harriet Chung,
nurse specialist and all clinical staff concerned at the Prince of Wales
Hospital for their contributions.
This study was supported by the European Foundation for Study of Diabetes,
the Chinese Diabetes Society, Lilly Foundation, Asia Diabetes Foundation
and Liao Wun Yuk Diabetes Memorial Fund, the latter under the Chinese
University of Hong Kong.
Author details
1Department of Medicine and Therapeutics, Prince of Wales Hospital, The
Chinese University of Hong Kong, Hong Kong SAR, China. 2Department of
Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China.
3Hong Kong Institute of Diabetes and Obesity, Hong Kong SAR, China. 4Asia
Diabetes Foundation, The Chinese University of Hong Kong, Hong Kong SAR,
China. 5The Association for the Improvement of Mental Health Programmes,
Geneva, Switzerland.
Received: 6 March 2015 Accepted: 4 August 2015
References
1. Chan JC, Cho NH, Tajima N, Shaw J. Diabetes in the Western Pacific Region-
Past, present and future. Diabetes Res Clin Pract. 2013;103(2):244–55.
2. Hidaka BH. Depression as a disease of modernity: explanations for
increasing prevalence. J Affect Disord. 2012;140(3):205–14.
3. Molosankwe I, Patel A, Jose Gagliardino J, Knapp M, McDaid D. Economic
aspects of the association between diabetes and depression: a systematic
review. J Affect Disord. 2012;142(Suppl):S42–55.
4. Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res
Clin Pract. 2010;87(3):302–12.
5. American Diabetes Association. Standards of medical care in diabetes–
2014. Diabetes Care. 2014;37 Suppl 1:S14–80.
6. International Diabetes Federation. Global Guideline for Type 2 Diabetes,
2012.
7. Radloff LS: The CES-D Scale: A Self-Report Depression Scale for Research in
the General Population. Applied Psychological Measurement, 1(3):385–481
8. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16(9):606–13.
9. Chen TM, Huang FY, Chang C, Chung H. Using the PHQ-9 for depression
screening and treatment monitoring for Chinese Americans in primary care.
Psychiatr Serv. 2006;57(7):976–81.
10. Yu X, Tam WW, Wong PT, Lam TH, Stewart SM. The Patient Health
Questionnaire-9 for measuring depressive symptoms among the general
population in Hong Kong. Compr Psychiatry. 2012;53(1):95–102.
11. Cheung CK, Bagley C. Validating an American scale in Hong Kong: the
Center for Epidemiological Studies Depression Scale (CES-D). J Psychol.
1998;132(2):169–86.
12. Cheng ST, Chan AC. The center for epidemiologic studies depression scale
in older chinese: thresholds for long and short forms. Int J Geriatr
Psychiatry. 2005;20(5):465–70.
13. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing
depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis.
CMAJ. 2012;184(3):E191–196.
14. Li Z, Hicks MH. The CES-D in Chinese American women: construct validity,
diagnostic validity for major depression, and cultural response bias.
Psychiatry Res. 2010;175(3):227–32.
15. Demirchyan A, Petrosyan V, Thompson ME. Psychometric value of the Center for
Epidemiologic Studies Depression (CES-D) scale for screening of depressive
symptoms in Armenian population. J Affect Disord. 2011;133(3):489–98.
16. Zhang Y, Ting R, Lam M, Lam J, Nan H, Yeung R, et al. Measuring depressive
symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese
subjects with type 2 diabetes. J Affect Disord. 2013;151(2):660–6.
17. So WY, Raboca J, Sobrepena L, Yoon KH, Deerochanawong C, Ho LT, et al.
Comprehensive risk assessments of diabetic patients from seven Asian
countries: The Joint Asia Diabetes Evaluation (JADE) program. J Diabetes.
2011;3(2):109–18.
18. Ko GT, So WY, Tong PC, Le Coguiec F, Kerr D, Lyubomirsky G, et al. From
design to implementation–the Joint Asia Diabetes Evaluation (JADE) program: a
descriptive report of an electronic web-based diabetes management program.
BMC medical informatics and decision making. 2010;10:26.
19. Chan JC, So W, Ko G, Tong P, Yang X, Ma R, et al. The Joint Asia Diabetes
Evaluation (JADE) Program: a web-based program to translate evidence to
clinical practice in Type 2 diabetes. Diabet Med. 2009;26(7):693–9.
20. Chan JC, Sui Y, Oldenburg B, Zhang Y, Chung HH, Goggins W, et al. Effects
of telephone-based peer support in patients with type 2 diabetes mellitus
receiving integrated care: a randomized clinical trial. JAMA Internal Med.
2014;174(6):972–81.
21. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic
Studies Depression Scale (CES-D) as a screening instrument for depression
among community-residing older adults. Psychology and aging.
1997;12(2):277–87.
22. Stahl D, Sum CF, Lum SS, Liow PH, Chan YH, Verma S, et al. Screening for
depressive symptoms: validation of the center for epidemiologic studies
Zhang et al. BMC Psychiatry  (2015) 15:198 Page 9 of 10
depression scale (CES-D) in a multiethnic group of patients with diabetes in
Singapore. Diabetes Care. 2008;31(6):1118–9.
23. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development
and validation of a structured diagnostic psychiatric interview for DSM-IV
and ICD-10. J Clin Psychiat. 1998;59 Suppl 20:22–33. quiz 34–57.
24. Chan JW, Lam SP, Li SX, Yu MW, Chan NY, Zhang J, et al. Eveningness and
insomnia: independent risk factors of nonremission in major depressive
disorder. Sleep. 2014;37(5):911–7.
25. Kim G, Decoster J, Huang CH, Chiriboga DA. Race/ethnicity and the factor
structure of the center for epidemiologic studies depression scale: a meta-
analysis. Cultur Diver Ethnic Minor Psychol. 2011;17(4):381–96.
26. Williams CD, Taylor TR, Makambi K, Harrell J, Palmer JR, Rosenberg L, et al.
CES-D four-factor structure is confirmed, but not invariant, in a large cohort
of African American women. Psychiat Res. 2007;150(2):173–80.
27. Makambi KH, Williams CD, Taylor TR, Rosenberg L, Adams-Campbell LL. An
assessment of the CES-D scale factor structure in black women: the black
women’s health study. Psychiat Res. 2009;168(2):163–70.
28. Wong YL. Measurement properties of the center for epidemiologic studies-
depression scale in a homeless population. Psychol Assess. 2000;12(1):69–76.
29. Edwards MC, Cheavens JS, Heiy JE, Cukrowicz KC. A reexamination of the
factor structure of the Center for Epidemiologic Studies Depression Scale: is
a one-factor model plausible? Psychol Assess. 2010;22(3):711–5.
30. Iwata N, Roberts CR, Kawakami N. Japan-U.S. comparison of responses
to depression scale items among adult workers. Psychiatry Res.
1995;58(3):237–45.
31. Cho MJ, Kim KH. Use of the Center for Epidemiologic Studies Depression
(CES-D) scale in Korea. J Nerv Ment Dis. 1998;186(5):304–10.
32. Jang Y, Kim G, Chiriboga D. Acculturation and manifestation of depressive
symptoms among Korean-American older adults. Aging Ment Health.
2005;9(6):500–7.
33. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for
depression and emotional problems in patients with diabetes: comparison
of screening characteristics of depression questionnaires, measurement of
diabetes-specific emotional problems and standard clinical assessment.
Diabetologia. 2006;49(3):469–77.
34. Yang HJ, Soong WT, Kuo PH, Chang HL, Chen WJ. Using the CES-D in a
two-phase survey for depressive disorders among nonreferred adolescents
in Taipei: a stratum-specific likelihood ratio analysis. J Affect Disord.
2004;82(3):419–30.
35. Khamseh ME, Baradaran HR, Javanbakht A, Mirghorbani M, Yadollahi Z,
Malek M. Comparison of the CES-D and PHQ-9 depression scales in people
with type 2 diabetes in Tehran, Iran. BMC Psychiatry. 2011;11:61.
36. Milette K, Hudson M, Baron M, Thombs BD, Canadian Scleroderma
Research G. Comparison of the PHQ-9 and CES-D depression scales in
systemic sclerosis: internal consistency reliability, convergent validity
and clinical correlates. Rheumatology. 2010;49(4):789–96.
37. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE.
Depression and poor glycemic control: a meta-analytic review of the
literature. Diabetes Care. 2000;23(7):934–42.
38. Waitzfelder B, Gerzoff RB, Karter AJ, Crystal S, Bair MJ, Ettner SL, et al.
Correlates of depression among people with diabetes: the Translating
Research Into Action for Diabetes (TRIAD) study. Primary Care Diabetes.
2010;4(4):215–22.
39. Pompili M, Lester D, Innamorati M, De Pisa E, Amore M, Ferrara C, et al.
Quality of life and suicide risk in patients with diabetes mellitus.
Psychosomatics. 2009;50(1):16–23.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zhang et al. BMC Psychiatry  (2015) 15:198 Page 10 of 10
